|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.200 GBX | 0.00% |
|
-1.18% | +5.00% |
| 31/03 | Poolbeg Pharma celebrates Australian patent "milestone" | AN |
| 31/03 | Stocks and gold up, Raspberry Pi hikes FTSE 250 | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 3.99Cr | - | - | - | - | - |
| 4.98TCr | |||||
| 4.7TCr | |||||
| 3.34TCr | - | ||||
| 2.42TCr | - | ||||
| 1.9TCr |
- Stock Market
- Equities
- POLB Stock
- Charts Poolbeg Pharma PLC
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition